Experimental Drug CS18 Shows Promise in Overcoming Therapy-Resistant Tumors, Baylor Researchers Find
Researchers at the Baylor College of Medicine have developed an experimental small-molecule drug known as CS18 that offers a potential new avenue for tackling tumors that have grown resistant to…